Evaluation of Safety and Efficacy of the FlexStent® Femoropopliteal Self-Expanding Stent System
Not Applicable
Completed
- Conditions
- Peripheral Artery DiseaseVascular DiseasePeripheral Vascular DiseaseCardiovascular DiseasesPAD
- Interventions
- Device: FlexStent® Femoropopliteal Self Expanding Stent System
- First Posted Date
- 2011-05-18
- Last Posted Date
- 2018-06-29
- Lead Sponsor
- Cordis Corporation
- Target Recruit Count
- 257
- Registration Number
- NCT01355406
- Locations
- 🇺🇸
El Camino Hospital, Mountain View, California, United States
🇺🇸University Hospital, Augusta, Georgia, United States
🇺🇸Allegheny General Hospital/Forbes Hospital, Pittsburgh, Pennsylvania, United States
An Observational Safety Evaluation of Patients Treated With the NEVO™ Sirolimus-eluting Coronary Stent. (NEVO II)
Phase 3
Terminated
- Conditions
- Atherosclerotic Coronary Artery Disease
- Interventions
- Device: NEVO™ Sirolimus-eluting Coronary Stent SystemDevice: XIENCE V®/XIENCE PRIME™/PROMUS® Everolimus-eluting Coronary Stent System)
- First Posted Date
- 2010-09-15
- Last Posted Date
- 2012-10-25
- Lead Sponsor
- Cordis Corporation
- Target Recruit Count
- 156
- Registration Number
- NCT01202058
- Locations
- 🇨🇭
Inselspital, Bern, Switzerland
🇪🇸Hospital Universitari Clinic de Barcelona, Barcelona, Spain
🇳🇱Erasmus MC - Thoraxcenter, Rotterdam, Netherlands
Cynergy: the CYPHER-NEVO Registry
Terminated
- Conditions
- Coronary Artery Disease
- First Posted Date
- 2010-04-19
- Last Posted Date
- 2011-07-12
- Lead Sponsor
- Cordis Corporation
- Target Recruit Count
- 14000
- Registration Number
- NCT01106378
- Locations
- 🇧🇷
Instituto do Coracão do Hospital das Clinicas da Faculdade de Medicina da Universidade de São Paulo, São Paulo, Brazil
🇰🇷Asan Medical Center, Seoul, Korea, Republic of
🇨🇭Clinique La Tour, Meyrin, Switzerland
A Multicenter, Open Label, Prospective, Non-Randomized Study Of INCRAFT™ In Subjects With AAA (INNOVATION)
Not Applicable
Completed
- Conditions
- Abdominal Aortic Aneurysms
- Interventions
- Device: Cordis AAA stent graft system "INCRAFT TM"
- First Posted Date
- 2010-04-19
- Last Posted Date
- 2023-01-12
- Lead Sponsor
- Cordis Corporation
- Target Recruit Count
- 60
- Registration Number
- NCT01106391
- Locations
- 🇩🇪
Universitat Leipzig Herzzentrum, Leipzig, Germany
The European Cobalt STent With Antiproliferative for Restenosis Trial (EuroSTAR Trial)
Phase 3
Completed
- Conditions
- Treatment of Symptomatic Ischemic Heart Disease
- Interventions
- Device: Conor Medsystems COSTAR™ stent (10 µg Paclitaxel)Device: Conor Medsystems COSTAR™ stent (30 µg Paclitaxel)
- First Posted Date
- 2009-09-10
- Last Posted Date
- 2010-05-17
- Lead Sponsor
- Cordis Corporation
- Target Recruit Count
- 282
- Registration Number
- NCT00974181
- Locations
- 🇮🇹
EMO Centro Cuore Columbus, Milan, Italy
CYPRESS - CYPHER for Evaluating Sustained Safety
Phase 4
- Conditions
- Coronary Artery Disease
- Interventions
- First Posted Date
- 2009-08-07
- Last Posted Date
- 2014-02-07
- Lead Sponsor
- Cordis Corporation
- Target Recruit Count
- 2509
- Registration Number
- NCT00954707
- Locations
- 🇺🇸
University Hospitals, Case Medical Center (Cleveland), Cleveland, Ohio, United States
French Post-Marketing Surveillance Survey
Phase 4
Terminated
- Conditions
- Coronary Artery Disease
- Interventions
- Device: Cypher stent ™ or Cypher Select ™
- First Posted Date
- 2009-03-04
- Last Posted Date
- 2010-11-29
- Lead Sponsor
- Cordis Corporation
- Target Recruit Count
- 4080
- Registration Number
- NCT00855478
The Study of the Crushing Technique Application Using SES in Coronary Bifurcations.
Phase 4
Completed
- Conditions
- Coronary Artery Disease
- Interventions
- Device: SES
- First Posted Date
- 2008-09-09
- Last Posted Date
- 2010-02-04
- Lead Sponsor
- Cordis Corporation
- Target Recruit Count
- 350
- Registration Number
- NCT00749424
- Locations
- 🇮🇹
Fondazione Centro San Raffaele del Monte Tabor, Milano, Italy
S.M.A.R.T.® Nitinol Self-Expandable Stent in the Treatment of Obstructive Superficial Femoral Artery Disease
Not Applicable
Completed
- Conditions
- Superficial Femoral Artery Disease
- Interventions
- Device: S.M.A.R.T. ® Stent
- First Posted Date
- 2008-08-21
- Last Posted Date
- 2014-04-17
- Lead Sponsor
- Cordis Corporation
- Target Recruit Count
- 250
- Registration Number
- NCT00739102
- Locations
- 🇺🇸
Columbia University Medical Center, New York, New York, United States
A Study of the Presillion Stent in de Novo Coronary Lesions
Phase 3
Completed
- Conditions
- Coronary Artery Disease
- Interventions
- Device: PRESILLION cobalt chromium stent
- First Posted Date
- 2008-07-25
- Last Posted Date
- 2010-06-14
- Lead Sponsor
- Cordis Corporation
- Target Recruit Count
- 101
- Registration Number
- NCT00722579
- Locations
- 🇧🇪
CHU de Liège, Liège, Belgium
© Copyright 2025. All Rights Reserved by MedPath